What is EO2 Concepts?
EO2 Concepts is at the forefront of advanced wound care, developing innovative solutions from its base in San Antonio, TX. The company's core offering is its Continuous Diffusion of Oxygen (CDO) therapy, delivered via the FDA-cleared OxyGeni system. This technology is designed to address challenging wound healing scenarios by providing continuous oxygenation and monitoring. EO2 Concepts targets healthcare professionals such as podiatrists, vascular surgeons, and plastic surgeons, aiming to improve patient mobility and reduce the need for costly referrals. Their focus on cost-effective, naturally antibacterial solutions supports the body's inherent healing mechanisms, enhancing patient outcomes and quality of life.
How much funding has EO2 Concepts raised?
EO2 Concepts has raised a total of $9.1M across 5 funding rounds:
Private Equity
$732K
Private Equity
$705K
Private Equity
$2.5M
Private Equity
$4.3M
Debt
$907K
Private Equity (2009): $732K, investors not publicly disclosed
Private Equity (2009): $705K, investors not publicly disclosed
Private Equity (2010): $2.5M, investors not publicly disclosed
Private Equity (2011): $4.3M, investors not publicly disclosed
Debt (2017): $907K, investors not publicly disclosed
What's next for EO2 Concepts?
The recent major strategic investment signals a pivotal phase for EO2 Concepts, likely enabling the company to scale its operations, expand its market reach, and further develop its proprietary CDO technology. This capital infusion is expected to bolster its position in the competitive advanced wound care sector, potentially leading to broader adoption of the OxyGeni system by healthcare providers. The company's commitment to enhancing patient mobility and quality of life through innovative oxygenation therapies positions it for continued growth and impact in the medical technology landscape.
See full EO2 Concepts company page
